Arcadia Biosciences (RKDA) Accumulated Expenses (2014 - 2025)

Arcadia Biosciences (RKDA) has 12 years of Accumulated Expenses data on file, last reported at $107000.0 in Q4 2025.

• Quarterly Accumulated Expenses fell 88.88% year-over-year to $107000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $107000.0 (down 88.88% YoY) and the FY2025 annual result came in at $107000.0, down 88.88% from the prior year.
• Accumulated Expenses eased to $107000.0 in Q4 2025, from $962000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.6 million in Q4 2021 to a low of $107000.0 in Q4 2025.
• A 5-year average of $1.0 million and a median of $1.1 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Accumulated Expenses soared 3468.89% — and 2025, when it plunged 88.88%.
• Tracing RKDA's Accumulated Expenses over 5 years: stood at $1.6 million in 2021, then dropped by 14.51% to $1.4 million in 2022, then declined by 18.5% to $1.1 million in 2023, then dropped by 14.03% to $962000.0 in 2024, then sank by 88.88% to $107000.0 in 2025.
• The last three Accumulated Expenses figures came in at $107000.0 (Q4 2025), $962000.0 (Q4 2024), and $1.1 million (Q4 2023), per Business Quant data.